SCHEMBL366026

SCHEMBL366026

[CH2]CN(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1219532 0.73
SCHEMBL15471203 0.69 KDM4E (0.38)
SCHEMBL13595534 0.69
SCHEMBL9829129 0.69
SCHEMBL150136 0.67
SCHEMBL11501923 0.67
SCHEMBL462822 0.67
SCHEMBL5962435 0.65
SCHEMBL21578839 0.64
SCHEMBL8308809 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106083855-B Purine derivatives useful as Hsp90 inhibitors 斯隆-凯特林癌症研究院 2020-04-10 CN claimed
US-10172863-B2 Purine derivatives useful as HSP90 inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2019-01-08 US claimed
EP-2646043-B1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC (US) 2017-02-15 EP claimed
US-20160310497-A1 PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2016-10-27 US claimed
US-9328114-B2 Hsp90 inhibitors SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2016-05-03 US claimed
US-20160052972-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC. 2016-02-25 US claimed
US-20150111815-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS S & T GLOBAL INC (US) 2015-04-23 US claimed
US-20140005100-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL, INC. 2014-01-02 US claimed
EP-2646043-A1 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T Global Inc. (US) 2013-10-09 EP claimed
US-20130210704-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2013-08-15 US claimed
WO-2012009715-A2 NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF A VIRAL INFECTION S&T GLOBAL INC. (US) 2012-01-19 WO claimed
EP-1802650-B1 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS INC (US) 2011-10-26 EP claimed
US-7718767-B2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection SCYNEXIS, INC. (US) 2010-05-18 US claimed
EP-1802650-A4 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS INC (US) 2008-08-20 EP claimed
EP-1802650-A2 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION Scynexis, Inc. (US) 2007-07-04 EP claimed
US-20060160727-A1 3-Ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection FLIRI HANS G 2006-07-20 US claimed
US-20060089301-A1 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection SCYNEXIS, INC. 2006-04-27 US claimed
WO-2006039668-A2 3-ETHER AND 3-THIOETHER SUBSTITUTED CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF HEPATITIS C INFECTION SCYNEXIS, INC (US) 2006-04-13 WO claimed
WO-1997043282-A2 BENZOTHIAZOLINONES AS ANTI-ASTHMATIC AGENTS KLINGE PHARMA GMBH (DE) 1997-11-20 WO claimed
WO-1997043292-A1 NEW THIAZOLOPYRIDINES KLINGE PHARMA GMBH (DE) 1997-11-20 WO claimed